GPT and metabolic dysfunction-associated steatotic liver disease: In the present study, among 60 patients with T2DM and NAFLD, changes from baseline at week 12 in FBS, TC, TG, SGPT, and vitD3 were significantly greater in the sitagliptin + metformin compared with the metformin group.